Comprehensive Physicochemical and Biological Characterization of the Proposed Biosimilar Darbepoetin Alfa, LBDE, and Its Originator Darbepoetin Alfa, NESP

Background For regulatory approval, the comparability of a biosimilar product to an originator product should be ensured through thorough physicochemical and biological characterization. Objective To evaluate the biosimilarity between LBDE, the proposed biosimilar darbepoetin alfa, and NESP ® , its...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy biopharmaceuticals, and gene therapy, 2018-04, Vol.32 (2), p.153-168
Hauptverfasser: Jeong, Yeong Ran, Jeong, Rae Ung, Son, Jeong Hyun, Kwon, Joon Cheol, Jung, Saem, Song, Mi A, Hwang, Jin Ah, Lee, Gyun Min
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background For regulatory approval, the comparability of a biosimilar product to an originator product should be ensured through thorough physicochemical and biological characterization. Objective To evaluate the biosimilarity between LBDE, the proposed biosimilar darbepoetin alfa, and NESP ® , its originator, we performed a comprehensive physicochemical and biological characterization study. Methods Primary and higher-order protein structures were analyzed using Lys-C peptide mapping with liquid chromatography–mass spectrometry (LC–MS), disulfide bond identification, circular dichroism, and fluorescence spectroscopy. Glycosylation and isoform distribution were analyzed using MS, LC, and capillary zone electrophoresis. Size variants were evaluated with size-exclusion chromatography–high-performance liquid chromatography (SEC-HPLC) and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Biological characterization included binding affinity for human erythropoietin receptor, in vitro cell proliferation, and in vivo potency. Pharmacokinetics (PK) were evaluated using rats through two injection routes. Results Non-reducing and reducing Lys-C peptide mapping showed a highly similar peak profile, confirming that LBDE and NESP ® have the same primary structure and disulfide bonds. Glycosylation and isoform analyses showed that the attached N -glycan and O -glycan structures were the same and their relative contents were similar. Spectroscopic analysis of LBDE showed indistinguishable spectra with NESP ® . For both LBDE and NESP ® , a very small amount of size variants was found in SEC-HPLC, and no minor bands were detected in SDS-PAGE. Furthermore, LBDE did not show any difference with NESP ® in the in vitro and in vivo functional analyses. PK parameters of LBDE were in good agreement with those of NESP ® . Conclusion LBDE shows high similarity to NESP ® with regard to structure and function.
ISSN:1173-8804
1179-190X
DOI:10.1007/s40259-018-0272-7